Global Active Pharmaceutical Ingredient (API) Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15312142 | Publishing Date : 20-Feb-2020 | No. of pages : 94
Detailed TOC of Global Active Pharmaceutical Ingredient (API) Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Active Pharmaceutical Ingredient (API) Revenue
1.4 Market Analysis by Type
1.4.1 Global Active Pharmaceutical Ingredient (API) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Innovative APIS Segment
1.4.3 Generic APIS Segment
1.5 Market by Application
1.5.1 Global Active Pharmaceutical Ingredient (API) Market Share by Application: 2020 VS 2026
1.5.2 Oncology
1.5.3 Diabetes
1.5.4 Cardiovascular Disease
1.5.5 Cns and Neurological Disorders
1.5.6 Orthopedic Disorders
1.5.7 Nephrology
1.5.8 Ophthalmology
1.5.9 Pulmonology
1.5.10 Gastrointestinal Disorders
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Active Pharmaceutical Ingredient (API) Market Perspective (2015-2026)
2.2 Active Pharmaceutical Ingredient (API) Growth Trends by Regions
2.2.1 Active Pharmaceutical Ingredient (API) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Active Pharmaceutical Ingredient (API) Historic Market Share by Regions (2015-2020)
2.2.3 Active Pharmaceutical Ingredient (API) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Active Pharmaceutical Ingredient (API) Market Growth Strategy
2.3.6 Primary Interviews with Key Active Pharmaceutical Ingredient (API) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Active Pharmaceutical Ingredient (API) Players by Market Size
3.1.1 Global Top Active Pharmaceutical Ingredient (API) Players by Revenue (2015-2020)
3.1.2 Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Players (2015-2020)
3.1.3 Global Active Pharmaceutical Ingredient (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Active Pharmaceutical Ingredient (API) Market Concentration Ratio
3.2.1 Global Active Pharmaceutical Ingredient (API) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredient (API) Revenue in 2019
3.3 Active Pharmaceutical Ingredient (API) Key Players Head office and Area Served
3.4 Key Players Active Pharmaceutical Ingredient (API) Product Solution and Service
3.5 Date of Enter into Active Pharmaceutical Ingredient (API) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Active Pharmaceutical Ingredient (API) Historic Market Size by Type (2015-2020)
4.2 Global Active Pharmaceutical Ingredient (API) Forecasted Market Size by Type (2021-2026)
5 Active Pharmaceutical Ingredient (API) Breakdown Data by Application (2015-2026)
5.1 Global Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020)
5.2 Global Active Pharmaceutical Ingredient (API) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Active Pharmaceutical Ingredient (API) Market Size (2015-2020)
6.2 Active Pharmaceutical Ingredient (API) Key Players in North America (2019-2020)
6.3 North America Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020)
6.4 North America Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Active Pharmaceutical Ingredient (API) Market Size (2015-2020)
7.2 Active Pharmaceutical Ingredient (API) Key Players in Europe (2019-2020)
7.3 Europe Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020)
7.4 Europe Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020)
8 China
8.1 China Active Pharmaceutical Ingredient (API) Market Size (2015-2020)
8.2 Active Pharmaceutical Ingredient (API) Key Players in China (2019-2020)
8.3 China Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020)
8.4 China Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Active Pharmaceutical Ingredient (API) Market Size (2015-2020)
9.2 Active Pharmaceutical Ingredient (API) Key Players in Japan (2019-2020)
9.3 Japan Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020)
9.4 Japan Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Active Pharmaceutical Ingredient (API) Market Size (2015-2020)
10.2 Active Pharmaceutical Ingredient (API) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020)
10.4 Southeast Asia Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020)
11 India
11.1 India Active Pharmaceutical Ingredient (API) Market Size (2015-2020)
11.2 Active Pharmaceutical Ingredient (API) Key Players in India (2019-2020)
11.3 India Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020)
11.4 India Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Active Pharmaceutical Ingredient (API) Market Size (2015-2020)
12.2 Active Pharmaceutical Ingredient (API) Key Players in Central & South America (2019-2020)
12.3 Central & South America Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020)
12.4 Central & South America Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Teva
13.1.1 Teva Company Details
13.1.2 Teva Business Overview and Its Total Revenue
13.1.3 Teva Active Pharmaceutical Ingredient (API) Introduction
13.1.4 Teva Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020))
13.1.5 Teva Recent Development
13.2 Sun Pharmaceutical
13.2.1 Sun Pharmaceutical Company Details
13.2.2 Sun Pharmaceutical Business Overview and Its Total Revenue
13.2.3 Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Introduction
13.2.4 Sun Pharmaceutical Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020)
13.2.5 Sun Pharmaceutical Recent Development
13.3 Aurobindo Pharma
13.3.1 Aurobindo Pharma Company Details
13.3.2 Aurobindo Pharma Business Overview and Its Total Revenue
13.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Introduction
13.3.4 Aurobindo Pharma Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020)
13.3.5 Aurobindo Pharma Recent Development
13.4 Albemarle
13.4.1 Albemarle Company Details
13.4.2 Albemarle Business Overview and Its Total Revenue
13.4.3 Albemarle Active Pharmaceutical Ingredient (API) Introduction
13.4.4 Albemarle Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020)
13.4.5 Albemarle Recent Development
13.5 Sigma-Aldrich
13.5.1 Sigma-Aldrich Company Details
13.5.2 Sigma-Aldrich Business Overview and Its Total Revenue
13.5.3 Sigma-Aldrich Active Pharmaceutical Ingredient (API) Introduction
13.5.4 Sigma-Aldrich Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020)
13.5.5 Sigma-Aldrich Recent Development
13.6 Mylan
13.6.1 Mylan Company Details
13.6.2 Mylan Business Overview and Its Total Revenue
13.6.3 Mylan Active Pharmaceutical Ingredient (API) Introduction
13.6.4 Mylan Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020)
13.6.5 Mylan Recent Development
13.7 Allergan
13.7.1 Allergan Company Details
13.7.2 Allergan Business Overview and Its Total Revenue
13.7.3 Allergan Active Pharmaceutical Ingredient (API) Introduction
13.7.4 Allergan Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020)
13.7.5 Allergan Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Active Pharmaceutical Ingredient (API) Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Active Pharmaceutical Ingredient (API) Key Market Segments
Table 2. Key Players Covered: Ranking by Active Pharmaceutical Ingredient (API) Revenue
Table 3. Ranking of Global Top Active Pharmaceutical Ingredient (API) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Active Pharmaceutical Ingredient (API) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Innovative APIS Segment
Table 6. Key Players of Generic APIS Segment
Table 7. Global Active Pharmaceutical Ingredient (API) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Active Pharmaceutical Ingredient (API) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Active Pharmaceutical Ingredient (API) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Active Pharmaceutical Ingredient (API) Market Share by Regions (2015-2020)
Table 11. Global Active Pharmaceutical Ingredient (API) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Active Pharmaceutical Ingredient (API) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Active Pharmaceutical Ingredient (API) Market Growth Strategy
Table 17. Main Points Interviewed from Key Active Pharmaceutical Ingredient (API) Players
Table 18. Global Active Pharmaceutical Ingredient (API) Revenue by Players (2015-2020) (Million US$)
Table 19. Global Active Pharmaceutical Ingredient (API) Market Share by Players (2015-2020)
Table 20. Global Top Active Pharmaceutical Ingredient (API) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredient (API) as of 2019)
Table 21. Global Active Pharmaceutical Ingredient (API) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Active Pharmaceutical Ingredient (API) Product Solution and Service
Table 24. Date of Enter into Active Pharmaceutical Ingredient (API) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020) (Million US$)
Table 27. Global Active Pharmaceutical Ingredient (API) Market Size Share by Type (2015-2020)
Table 28. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2021-2026)
Table 29. Global Active Pharmaceutical Ingredient (API) Market Size Share by Application (2015-2020)
Table 30. Global Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020) (Million US$)
Table 31. Global Active Pharmaceutical Ingredient (API) Market Size Share by Application (2021-2026)
Table 32. North America Key Players Active Pharmaceutical Ingredient (API) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Active Pharmaceutical Ingredient (API) Market Share (2019-2020)
Table 34. North America Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020) (Million US$)
Table 35. North America Active Pharmaceutical Ingredient (API) Market Share by Type (2015-2020)
Table 36. North America Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020) (Million US$)
Table 37. North America Active Pharmaceutical Ingredient (API) Market Share by Application (2015-2020)
Table 38. Europe Key Players Active Pharmaceutical Ingredient (API) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Active Pharmaceutical Ingredient (API) Market Share (2019-2020)
Table 40. Europe Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Active Pharmaceutical Ingredient (API) Market Share by Type (2015-2020)
Table 42. Europe Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Active Pharmaceutical Ingredient (API) Market Share by Application (2015-2020)
Table 44. China Key Players Active Pharmaceutical Ingredient (API) Revenue (2019-2020) (Million US$)
Table 45. China Key Players Active Pharmaceutical Ingredient (API) Market Share (2019-2020)
Table 46. China Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020) (Million US$)
Table 47. China Active Pharmaceutical Ingredient (API) Market Share by Type (2015-2020)
Table 48. China Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020) (Million US$)
Table 49. China Active Pharmaceutical Ingredient (API) Market Share by Application (2015-2020)
Table 50. Japan Key Players Active Pharmaceutical Ingredient (API) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Active Pharmaceutical Ingredient (API) Market Share (2019-2020)
Table 52. Japan Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Active Pharmaceutical Ingredient (API) Market Share by Type (2015-2020)
Table 54. Japan Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Active Pharmaceutical Ingredient (API) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Active Pharmaceutical Ingredient (API) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Active Pharmaceutical Ingredient (API) Market Share (2019-2020)
Table 58. Southeast Asia Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Active Pharmaceutical Ingredient (API) Market Share by Type (2015-2020)
Table 60. Southeast Asia Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Active Pharmaceutical Ingredient (API) Market Share by Application (2015-2020)
Table 62. India Key Players Active Pharmaceutical Ingredient (API) Revenue (2019-2020) (Million US$)
Table 63. India Key Players Active Pharmaceutical Ingredient (API) Market Share (2019-2020)
Table 64. India Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020) (Million US$)
Table 65. India Active Pharmaceutical Ingredient (API) Market Share by Type (2015-2020)
Table 66. India Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020) (Million US$)
Table 67. India Active Pharmaceutical Ingredient (API) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Active Pharmaceutical Ingredient (API) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Active Pharmaceutical Ingredient (API) Market Share (2019-2020)
Table 70. Central & South America Active Pharmaceutical Ingredient (API) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Active Pharmaceutical Ingredient (API) Market Share by Type (2015-2020)
Table 72. Central & South America Active Pharmaceutical Ingredient (API) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Active Pharmaceutical Ingredient (API) Market Share by Application (2015-2020)
Table 74. Teva Company Details
Table 75. Teva Business Overview
Table 76. Teva Product
Table 77. Teva Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020) (Million US$)
Table 78. Teva Recent Development
Table 79. Sun Pharmaceutical Company Details
Table 80. Sun Pharmaceutical Business Overview
Table 81. Sun Pharmaceutical Product
Table 82. Sun Pharmaceutical Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020) (Million US$)
Table 83. Sun Pharmaceutical Recent Development
Table 84. Aurobindo Pharma Company Details
Table 85. Aurobindo Pharma Business Overview
Table 86. Aurobindo Pharma Product
Table 87. Aurobindo Pharma Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020) (Million US$)
Table 88. Aurobindo Pharma Recent Development
Table 89. Albemarle Company Details
Table 90. Albemarle Business Overview
Table 91. Albemarle Product
Table 92. Albemarle Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020) (Million US$)
Table 93. Albemarle Recent Development
Table 94. Sigma-Aldrich Company Details
Table 95. Sigma-Aldrich Business Overview
Table 96. Sigma-Aldrich Product
Table 97. Sigma-Aldrich Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020) (Million US$)
Table 98. Sigma-Aldrich Recent Development
Table 99. Mylan Company Details
Table 100. Mylan Business Overview
Table 101. Mylan Product
Table 102. Mylan Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020) (Million US$)
Table 103. Mylan Recent Development
Table 104. Allergan Company Details
Table 105. Allergan Business Overview
Table 106. Allergan Product
Table 107. Allergan Revenue in Active Pharmaceutical Ingredient (API) Business (2015-2020) (Million US$)
Table 108. Allergan Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Active Pharmaceutical Ingredient (API) Market Share by Type: 2020 VS 2026
Figure 2. Innovative APIS Segment Features
Figure 3. Generic APIS Segment Features
Figure 4. Global Active Pharmaceutical Ingredient (API) Market Share by Application: 2020 VS 2026
Figure 5. Oncology Case Studies
Figure 6. Diabetes Case Studies
Figure 7. Cardiovascular Disease Case Studies
Figure 8. Cns and Neurological Disorders Case Studies
Figure 9. Orthopedic Disorders Case Studies
Figure 10. Nephrology Case Studies
Figure 11. Ophthalmology Case Studies
Figure 12. Pulmonology Case Studies
Figure 13. Gastrointestinal Disorders Case Studies
Figure 14. Active Pharmaceutical Ingredient (API) Report Years Considered
Figure 15. Global Active Pharmaceutical Ingredient (API) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Active Pharmaceutical Ingredient (API) Market Share by Regions: 2020 VS 2026
Figure 17. Global Active Pharmaceutical Ingredient (API) Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Active Pharmaceutical Ingredient (API) Market Share by Players in 2019
Figure 20. Global Top Active Pharmaceutical Ingredient (API) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredient (API) as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Active Pharmaceutical Ingredient (API) Revenue in 2019
Figure 22. North America Active Pharmaceutical Ingredient (API) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Active Pharmaceutical Ingredient (API) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Active Pharmaceutical Ingredient (API) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Active Pharmaceutical Ingredient (API) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Active Pharmaceutical Ingredient (API) Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Active Pharmaceutical Ingredient (API) Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Active Pharmaceutical Ingredient (API) Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Teva Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2015-2020)
Figure 31. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sun Pharmaceutical Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2015-2020)
Figure 33. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Aurobindo Pharma Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2015-2020)
Figure 35. Albemarle Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Albemarle Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2015-2020)
Figure 37. Sigma-Aldrich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Sigma-Aldrich Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2015-2020)
Figure 39. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Mylan Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2015-2020)
Figure 41. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Allergan Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Keyplayers in Global Active Pharmaceutical Ingredient (API) Market Size, Status and Forecast 2020-2026
TevaSun Pharmaceutical
Aurobindo Pharma
Albemarle
Sigma-Aldrich
Mylan
Allergan